Prospera Financial Services’s BioMarin Pharmaceuticals BMRN Stock Holding History

Prospera Financial Services’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$215K	Buy	+3,766	New	+$206K	﹤0.01%	1370
2026 Q1	–	Sell	-3,395	Closed	-$202K	–	1427
2025 Q4	$202K	Buy	+3,395	New	+$185K	﹤0.01%	1300
2024 Q1	–	Sell	-2,398	Closed	-$231K	–	1098
2023 Q4	$231K	Buy	+2,398	New	+$212K	0.01%	953
2022 Q3	–	Sell	-1,466	Closed	-$121K	–	921
2022 Q2	$121K	Sell	1,466 -218	-13%	-$17.4K	0.01%	852
2022 Q1	$130K	Buy	+1,684	New	+$141K	0.01%	1027
2020 Q4	–	Sell	-375	Closed	-$29K	–	782
2020 Q3	$29K	Buy	+375	New	+$37.9K	0.01%	782

Other funds holding BMRN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Prospera Financial Services's BMRN Position: Q2 2026 in Review

Prospera Financial Services opened a new position in BioMarin Pharmaceuticals (BMRN) in Q2 2026: 3,766 shares worth $215K. The stake represents ﹤0.01% of the portfolio and ranks #1370 among its holdings. This is a return to the name: Prospera Financial Services previously reported a position in BMRN as recently as Q4 2025.

Prospera Financial Services first reported a position in BMRN in Q3 2020 and has held it in 6 quarters since. The position peaked at $231K in Q4 2023. 565 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.

Prospera Financial Services held 3,766 shares of BioMarin Pharmaceuticals worth $215K as of Q2 2026.
BioMarin Pharmaceuticals was a new Prospera Financial Services position in Q2 2026.
BioMarin Pharmaceuticals made up ﹤0.01% of Prospera Financial Services's portfolio in Q2 2026, its #1370 holding.
Prospera Financial Services first reported a position in BioMarin Pharmaceuticals in Q3 2020 and has held it in 6 quarters since.
Prospera Financial Services's BioMarin Pharmaceuticals position peaked at $231K in Q4 2023.
565 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.

Based on Prospera Financial Services's 13F filing for Q2 2026, filed 15 Jul 2026.